276 related articles for article (PubMed ID: 33636351)
41. Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk.
Barthold D; Joyce G; Diaz Brinton R; Wharton W; Kehoe PG; Zissimopoulos J
PLoS One; 2020; 15(3):e0229541. PubMed ID: 32130251
[TBL] [Abstract][Full Text] [Related]
42. Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
Khan MS; Fonarow GC; Khan H; Greene SJ; Anker SD; Gheorghiade M; Butler J
ESC Heart Fail; 2017 Nov; 4(4):402-408. PubMed ID: 28869332
[TBL] [Abstract][Full Text] [Related]
43. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in hypertensive patients with myocardial infarction or heart failure: a systematic review and meta-analysis.
Ohtsubo T; Shibata R; Kai H; Okamoto R; Kumagai E; Kawano H; Fujiwara A; Kitazono T; Murohara T; Arima H
Hypertens Res; 2019 May; 42(5):641-649. PubMed ID: 30948834
[TBL] [Abstract][Full Text] [Related]
44. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
Wang Z; Zhang D; Wang S; Jin Y; Huan J; Wu Y; Xia C; Li Z; Qi X; Zhang D; Han X; Zhu X; Qu Y; Wang Q
Med Sci Monit; 2020 Sep; 26():e926651. PubMed ID: 32969367
[TBL] [Abstract][Full Text] [Related]
45. RAAS inhibition and the course of Alport syndrome.
Savva I; Pierides A; Deltas C
Pharmacol Res; 2016 May; 107():205-210. PubMed ID: 26995302
[TBL] [Abstract][Full Text] [Related]
46. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
Zhao HJ; Li Y; Liu SM; Sun XG; Li M; Hao Y; Cui LQ; Wang AH
Ren Fail; 2016 Jul; 38(6):849-56. PubMed ID: 27055479
[TBL] [Abstract][Full Text] [Related]
47. Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma.
Barone M; Viggiani MT; Losurdo G; Principi M; Leo AD
World J Gastroenterol; 2019 May; 25(20):2524-2538. PubMed ID: 31171895
[TBL] [Abstract][Full Text] [Related]
48. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives.
Ribeiro VT; de Souza LC; Simões E Silva AC
Protein Pept Lett; 2020; 27(6):484-511. PubMed ID: 31886744
[TBL] [Abstract][Full Text] [Related]
49. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study.
Kristensen KE; Torp-Pedersen C; Gislason GH; Egfjord M; Rasmussen HB; Hansen PR
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):733-40. PubMed ID: 25633315
[TBL] [Abstract][Full Text] [Related]
50. Renin-angiotensin System Inhibitors and Development of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Asgharzadeh F; Jafarzadeh-Esfehani R; Hassanian SM; Ferns GA; Avan A; Khazaei M
Curr Pharm Des; 2020; 26(39):5079-5085. PubMed ID: 32660400
[TBL] [Abstract][Full Text] [Related]
51. Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study.
Hallas J; Christensen R; Andersen M; Friis S; Bjerrum L
Br J Clin Pharmacol; 2012 Jul; 74(1):180-8. PubMed ID: 22243442
[TBL] [Abstract][Full Text] [Related]
52. The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer.
Mandilaras V; Bouganim N; Yin H; Asselah J; Azoulay L
Br J Cancer; 2017 Jan; 116(1):103-108. PubMed ID: 27846200
[TBL] [Abstract][Full Text] [Related]
53. [Influence of Renin-angiotensin System Blockage on Recurrence of Non-muscle-invasive Bladder Cancer].
Bai YJ; Wang XM; Han P; Yang YB; Tang Y; Wei Q; Wang J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 49(4):635-639. PubMed ID: 30378319
[TBL] [Abstract][Full Text] [Related]
54. Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials.
Khatib R; Joseph P; Briel M; Yusuf S; Healey J
Int J Cardiol; 2013 Apr; 165(1):17-24. PubMed ID: 22421406
[TBL] [Abstract][Full Text] [Related]
55. The effect of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on mortality in patients with chronic kidney disease: a meta-analysis of observational studies.
Qin Y; Chen T; Chen Q; Lv JY; Qi N; Wu C; He J
Pharmacoepidemiol Drug Saf; 2016 May; 25(5):503-11. PubMed ID: 26786323
[TBL] [Abstract][Full Text] [Related]
56. Prevention of recurrent atrial fibrillation with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a systematic review and meta-analysis of randomized trials.
Bhuriya R; Singh M; Sethi A; Molnar J; Bahekar A; Singh PP; Khosla S; Arora R
J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):178-84. PubMed ID: 21285399
[TBL] [Abstract][Full Text] [Related]
57. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis.
Caldeira D; Alarcão J; Vaz-Carneiro A; Costa J
BMJ; 2012 Jul; 345():e4260. PubMed ID: 22786934
[TBL] [Abstract][Full Text] [Related]
58. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
Zheng B; Kang J; Tian Y; Tang R; Long D; Yu R; He H; Zhang M; Shi L; Tao H; Liu X; Dong J; Ma C
Acta Cardiol; 2009 Jun; 64(3):335-40. PubMed ID: 19593943
[TBL] [Abstract][Full Text] [Related]
59. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials.
Bangalore S; Fakheri R; Toklu B; Ogedegbe G; Weintraub H; Messerli FH
Mayo Clin Proc; 2016 Jan; 91(1):51-60. PubMed ID: 26763511
[TBL] [Abstract][Full Text] [Related]
60. The evolving landscape of RAAS inhibition: from ACE inhibitors to ARBs, to DRIs and beyond.
Epstein BJ; Leonard PT; Shah NK
Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):713-25. PubMed ID: 22894628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
